Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Fintech Innovation ETF (ARKF) vs FMC Corp (FMC) Price & Performance

ARK Fintech Innovation ETF
FMC Corp

Price performance

Price movement over the last 24 hours

Key statistics

ARK Fintech Innovation ETF vs FMC Corp — how do they compare? ARK Fintech Innovation ETF trades at $41.45, while FMC Corp trades at $10.93 (market cap $1.37B). The key difference: FMC Corp pays a 2.93% dividend while ARK Fintech Innovation ETF pays none, and ARK Fintech Innovation ETF is trading nearer its 52-week high, FMC Corp nearer its low. Which is the better fit depends on your goals.

ARKFFMC
Sector
Sector/ThematicBasic Materials
52-Week High
$58.82$43.90
52-Week Low
$36.14$10.80
Market Cap
$1.37B
Enterprise Value
$5.51B
Dividend Yield
2.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Fintech Innovation ETF

ARKF trades at $41.63, up 0.43% with bullish technical signals from moving averages and strong trend strength (ADX 39.69). The stock faces resistance at $42 with support at $41. Recent coverage highlights institutional interest in Cathie Wood's and Bill Ackman's overlapping investments in Magnificent Seven stocks.

The ETF's outlook is supported by technical momentum but lacks fundamental financial data disclosure. Key risks include market volatility and dependency on top holdings performance. Institutional overlap suggests confidence in selected growth stocks, though valuation metrics remain undisclosed.

FMC Corp

FMC Corporation (FMC) trades at $10.91, showing minimal daily movement with a 0.18% gain. The stock faces significant fundamental challenges, including a net loss of -$2.24 billion in 2025 and negative profit margins, though recent strategic moves like a $400 million investment from Tessenderlo Group and asset sales aim to reduce debt. Technical indicators are bearish, with the stock trading near key support levels. Analyst sentiment is mixed, with a near-even split between Buy and Hold ratings but a consensus price target of $17.00 suggesting substantial upside potential from current levels.

The outlook for FMC hinges on successful debt reduction and the commercial success of new products like rimisoxafen. While the current valuation metrics (P/S: 0.4, P/B: 0.75) appear attractive, the deeply negative profitability and high debt load present significant risks. The potential for a operational turnaround exists, but investors should weigh the high risk of continued losses against the possibility of a recovery driven by new technology and improved financial health.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Fintech Innovation ETF

ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.

Read more on ARKF

About FMC Corp

FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.

Read more on FMC